Nicorette Quickmist (Nicotine)

Nicotine, the active ingredient in Nicorette Quickmist, is a nicotine replacement therapy presented as an oral spray for oromucosal use. It helps adult smokers quit by reducing nicotine withdrawal symptoms and cravings. GNH USA supplies Nicorette Quickmist as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicorette Quickmist is a nicotine replacement product used in the management of nicotine dependence and smoking cessation. - Smoking cessation: assists adult smokers in quitting by alleviating withdrawal symptoms. - Nicotine dependence: provides a controlled nicotine dose to facilitate gradual reduction of nicotine intake. - Relapse prevention: supports former smokers in maintaining abstinence from tobacco use.

Nicorette Quickmist may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Throat irritation: mild discomfort or soreness in the throat after use. - Mouth irritation: tingling or burning sensation in the oral cavity. - Cough: transient cough following spray administration. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives indicating hypersensitivity. - Chest pain: unexpected discomfort that may signal cardiovascular stress. - Severe dizziness or fainting: sudden loss of balance or consciousness requiring medical attention.

Before using Nicorette Quickmist, consider the following safety measures. - Assess nicotine dependence: evaluate smoking history and level of dependence prior to initiation. - Avoid use in children: product is not intended for individuals under 18 years of age. - Do not use with other nicotine products: concurrent use may increase nicotine exposure. - Monitor for cardiovascular symptoms: advise users with heart disease to consult a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and heat.

Nicorette Quickmist can interact with certain medications, requiring caution.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Certain antidepressants (e.g., bupropion): may raise seizure risk.

Moderate Interactions (Monitor Closely): - Caffeine: may enhance jitteriness or palpitations. - Alcohol: may potentiate nicotine’s cardiovascular effects. - Beta‑blockers: may mask tachycardia caused by nicotine.